Fibrinogen Alpha Chain Precursor and Apolipoprotein A-I in Urine as Biomarkers for Noninvasive Diagnosis of Calcium Oxalate Nephrolithiasis: A Proteomics Study
Table 2
Distribution of value-specific markers between nephrolithiasisand healthy control.
MRI (SD)b in nephrolithiasis
MRI (SD)b in healthy control
Regulation in nephrolithiasis
valuec
1207.23
3.64 (1.82)
7.85 (1.12)
↓
0.00856
2773.86
83.95 (28.39)
27.53 (15.98)
↑
0.00867
6182.87
144.19 (66.93)
38.66 (17.53)
↑
0.00878
2847.86
93.37 (67.89)
517.79 (105.24)
↓
0.0012
6295.88
112.66 (79.63)
647 (152.98)
↓
0.00168
4754.38
202.07 (169.92)
603.03 (148.77)
↓
0.00216
6131.83
49.73 (22.97)
202.03 (46.99)
↓
0.00216
6083.70
15.22 (5.15)
53.19 (12.59)
↓
0.00302
6069.56
15.7 (5.36)
48.95 (11.46)
↓
0.00302
2830.18
54.1 (23.42)
22.1 (9.66)
↑
0.00325
6327.86
6.39 (2.26)
20.96 (5.87)
↓
0.00642
2757.24
389.82 (183.01)
172.63 (111.86)
↑
0.0279
2726.01
34.08 (12.71)
19.42 (7.81)
↑
0.0314
, average mass.
bMRI, mean relative intensity. value calculated with -test. Statistical significance was considered at .
